Filtered By:
Cancer: Liver Cancer

This page shows you your search results in order of relevance. This is page number 8.

Order by Relevance | Date

Total 36590 results found since Jan 2013.

The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma
CONCLUSIONS: To conclude, the field regarding the link between gut microbiome as a non-invasive biomarkers and early detection of pancreatic cancer and hepatocellular carcinoma exists, however, it is not well-investigated. Additionally, many of the studies were conducted with small sample sizes, whereas biomarkers are ethnicity-dependent and should be validated in wide range of populations. Nevertheless, these aspects are promising and open up new diagnostic options.PMID:34919227 | DOI:10.26355/eurrev_202112_27421
Source: European Review for Medical and Pharmacological Sciences - December 17, 2021 Category: Drugs & Pharmacology Authors: K Ka źmierczak-Siedlecka E Stachowska M Folwarski K Przew łócka W Makarewicz E Bryl Source Type: research

The relationship between NTCP gene varieties and the progress of liver disease after HBV infection: an updated systematic review and meta-analysis
CONCLUSIONS: Rs2296651 polymorphism (A allele) may protect HBV infection and the progress of HBV-related disease (HBV-related HCC). And future researches about other single nucleotide polymorphisms (SNPs) (rs4646287, rs7154439, rs4646295, rs4646296) of NTCP may be needed to clarify the relationship of NTCP gene variety with HBV infection and HBV-related disease.PMID:35398032 | DOI:10.1016/j.amjms.2022.03.014
Source: The American Journal of the Medical Sciences - April 10, 2022 Category: General Medicine Authors: Chuan He Hong-Yan He Chang-Feng Sun Suvash Chandra Ojha Hang Wang Cun-Liang Deng Yun-Jian Sheng Source Type: research

Role of Trans-Arterial Chemoembolization (TACE) in patients with hepatocellular carcinoma
CONCLUSIONS: TACE is a low-cost palliative treatment for HCC. The initial tumor size is an independent predictor of survival.PMID:36196724 | DOI:10.26355/eurrev_202209_29776
Source: European Review for Medical and Pharmacological Sciences - October 5, 2022 Category: Drugs & Pharmacology Authors: A-A Meshari Source Type: research